Cincinnati Children’s Hospital Medical Center
Identification of cellular diversity and tumor-initiating cells driving NF-to-MPNST and drug resistance by single-cell multiomics for targeted therapy
Supported in part by Hanna's Hoops 4 Healing
Baylor College of Medicine
T cells expressing a next-generation glypican-3-specific CAR incorporating IL-7 receptor signaling to cure pediatric liver cancers
University of California Los Angeles
Utilizing Pluripotent Stem Cells to Evaluate the Role KIT and KRAS Play in Germ Cell Development and Tumorigenesis
Johns Hopkins University - School of Medicine
Investigating novel glutamine antagonists as a therapeutic strategy for malignant peripheral nerve sheath tumors
Texas Children's Hospital, Baylor College of Medicine
Glypican-3 specific T-cells for the adoptive immunotherapy of pediatric liver cancers
Mayo Clinic
The role of the de-ubiquitinase USP44 in childhood germ cell tumorigenesis
Children's Hospital of Wisconsin, Medical College of Wisconsin
A Phase I/II Trial Evaluating NK Cell Immunotherapy in Relapsed and Refractory Pediatric Solid Tumors
Lombardi Cancer Center at Georgetown University
Develop Small Molecule Yap Inhibitors to Treat Childhood Cancer
Children's National Medical Center
Phase I Dose Escalation Study of Sorafenib/Irinotecan Combination Therapy in Pediatric Relapsed Solid Tumors
